Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 2
1999 2
2000 2
2001 1
2002 1
2003 3
2004 2
2006 1
2007 2
2008 2
2009 1
2010 3
2011 2
2012 5
2013 6
2014 6
2015 4
2016 3
2017 5
2018 6
2019 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
Going viral with cancer immunotherapy.
Lichty BD, Breitbach CJ, Stojdl DF, Bell JC. Lichty BD, et al. Among authors: stojdl df. Nat Rev Cancer. 2014 Aug;14(8):559-67. doi: 10.1038/nrc3770. Epub 2014 Jul 3. Nat Rev Cancer. 2014. PMID: 24990523 Review.
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.
Bourgeois-Daigneault MC, Roy DG, Aitken AS, El Sayes N, Martin NT, Varette O, Falls T, St-Germain LE, Pelin A, Lichty BD, Stojdl DF, Ungerechts G, Diallo JS, Bell JC. Bourgeois-Daigneault MC, et al. Among authors: stojdl df. Sci Transl Med. 2018 Jan 3;10(422):eaao1641. doi: 10.1126/scitranslmed.aao1641. Sci Transl Med. 2018. PMID: 29298865
Development and applications of oncolytic Maraba virus vaccines.
Pol JG, Atherton MJ, Bridle BW, Stephenson KB, Le Boeuf F, Hummel JL, Martin CG, Pomoransky J, Breitbach CJ, Diallo JS, Stojdl DF, Bell JC, Wan Y, Lichty BD. Pol JG, et al. Among authors: stojdl df. Oncolytic Virother. 2018 Nov 26;7:117-128. doi: 10.2147/OV.S154494. eCollection 2018. Oncolytic Virother. 2018. PMID: 30538968 Free PMC article. Review.
Customized Viral Immunotherapy for HPV-Associated Cancer.
Atherton MJ, Stephenson KB, Pol J, Wang F, Lefebvre C, Stojdl DF, Nikota JK, Dvorkin-Gheva A, Nguyen A, Chen L, Johnson-Obaseki S, Villeneuve PJ, Diallo JS, Dimitroulakos J, Wan Y, Lichty BD. Atherton MJ, et al. Among authors: stojdl df. Cancer Immunol Res. 2017 Oct;5(10):847-859. doi: 10.1158/2326-6066.CIR-17-0102. Epub 2017 Sep 14. Cancer Immunol Res. 2017. PMID: 28912369 Free article.
An integrated stress response regulates amino acid metabolism and resistance to oxidative stress.
Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, Stojdl DF, Bell JC, Hettmann T, Leiden JM, Ron D. Harding HP, et al. Among authors: stojdl df. Mol Cell. 2003 Mar;11(3):619-33. doi: 10.1016/s1097-2765(03)00105-9. Mol Cell. 2003. PMID: 12667446 Free article.
Transforming the prostatic tumor microenvironment with oncolytic virotherapy.
Atherton MJ, Stephenson KB, Tzelepis F, Bakhshinyan D, Nikota JK, Son HH, Jirovec A, Lefebvre C, Dvorkin-Gheva A, Ashkar AA, Wan Y, Stojdl DF, Belanger EC, Breau RH, Bell JC, Saad F, Singh SK, Diallo JS, Lichty BD. Atherton MJ, et al. Among authors: stojdl df. Oncoimmunology. 2018 Mar 27;7(7):e1445459. doi: 10.1080/2162402X.2018.1445459. eCollection 2018. Oncoimmunology. 2018. PMID: 29900060 Free PMC article.
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials.
Pol JG, Acuna SA, Yadollahi B, Tang N, Stephenson KB, Atherton MJ, Hanwell D, El-Warrak A, Goldstein A, Moloo B, Turner PV, Lopez R, LaFrance S, Evelegh C, Denisova G, Parsons R, Millar J, Stoll G, Martin CG, Pomoransky J, Breitbach CJ, Bramson JL, Bell JC, Wan Y, Stojdl DF, Lichty BD, McCart JA. Pol JG, et al. Among authors: stojdl df. Oncoimmunology. 2018 Sep 19;8(1):e1512329. doi: 10.1080/2162402X.2018.1512329. eCollection 2019. Oncoimmunology. 2018. PMID: 30546947 Free PMC article.
Characterizing Cellular Responses During Oncolytic Maraba Virus Infection.
Hassanzadeh G, Naing T, Graber T, Jafarnejad SM, Stojdl DF, Alain T, Holcik M. Hassanzadeh G, et al. Among authors: stojdl df. Int J Mol Sci. 2019 Jan 29;20(3):580. doi: 10.3390/ijms20030580. Int J Mol Sci. 2019. PMID: 30700020 Free PMC article.
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.
Ilkow CS, Marguerie M, Batenchuk C, Mayer J, Ben Neriah D, Cousineau S, Falls T, Jennings VA, Boileau M, Bellamy D, Bastin D, de Souza CT, Alkayyal A, Zhang J, Le Boeuf F, Arulanandam R, Stubbert L, Sampath P, Thorne SH, Paramanthan P, Chatterjee A, Strieter RM, Burdick M, Addison CL, Stojdl DF, Atkins HL, Auer RC, Diallo JS, Lichty BD, Bell JC. Ilkow CS, et al. Among authors: stojdl df. Nat Med. 2015 May;21(5):530-6. doi: 10.1038/nm.3848. Epub 2015 Apr 20. Nat Med. 2015. PMID: 25894825
High-throughput screening to enhance oncolytic virus immunotherapy.
Allan KJ, Stojdl DF, Swift SL. Allan KJ, et al. Among authors: stojdl df. Oncolytic Virother. 2016 Apr 5;5:15-25. doi: 10.2147/OV.S66217. eCollection 2016. Oncolytic Virother. 2016. PMID: 27579293 Free PMC article. Review.
59 results
Jump to page
Feedback